Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 295, Issue 3, Pages H1191-H1197Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.00577.2008
Keywords
purines; contractility; infarction
Funding
- National Heart, Lung, and Blood Institute [RO1-HL-48225]
- Ray Neag Distinguished Professorship
- National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048225] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031127] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Evidence is accumulating to support the presence of P2X purinergic receptors in the heart. However, the biological role of this receptor remains to be defined. The objectives here were to determine the role of cardiac P2X receptors in modulating the progression of post-myocardial infarction ischemic heart failure and to investigate the underlying mechanism. The P2X(4) receptor (P2X(4)R) is an important subunit of native cardiac P2X receptors, and the cardiac-specific transgenic overexpression of P2X(4)R (Tg) was developed as a model. Left anterior descending artery ligation resulted in similar infarct size between Tg and wildtype (WT) mice (P > 0.1). However, Tg mice showed an enhanced cardiac contractile performance at 7 days, 1 mo, and 2 mo after infarction and an increased survival at 1 and 2 mo after infarction (P < 0.01). The enhanced intact heart function was manifested by a greater global left ventricular developed pressure and rate of contraction of left ventricular pressure in vitro and by a significantly increased fractional shortening and systolic thickening in the noninfarcted region in vivo (P < 0.05). The salutary effects on the ischemic heart failure phenotype were seen in both sexes and were not the result of any difference in infarct size in Tg versus WT hearts. An enhanced contractile function of the noninfarcted area in the Tg heart was likely an important rescuing mechanism. The cardiac P2X receptor is a novel target to treat post-myocardial infarction ischemic heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available